Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2006 1
2010 1
2012 1
2015 3
2016 1
2018 1
2019 1
2020 1
2022 2
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Hypertrophic cardiomyopathy: a systematic review.
Maron BJ. Maron BJ. JAMA. 2002 Mar 13;287(10):1308-20. doi: 10.1001/jama.287.10.1308. JAMA. 2002. PMID: 11886323 Review.
CONTEXT: Throughout the past 40 years, a vast and sometimes contradictory literature has accumulated regarding hypertrophic cardiomyopathy (HCM), a genetic cardiac disease caused by a variety of mutations in genes encoding sarcomeric proteins and characterized by a …
CONTEXT: Throughout the past 40 years, a vast and sometimes contradictory literature has accumulated regarding hypertrophic cardio …
Alcohol septal ablation versus surgical septal myectomy of obstructive hypertrophic cardiomyopathy: systematic review and meta-analysis.
Yokoyama Y, Shimoda T, Shimada YJ, Shimamura J, Akita K, Yasuda R, Takayama H, Kuno T. Yokoyama Y, et al. Eur J Cardiothorac Surg. 2023 Mar 1;63(3):ezad043. doi: 10.1093/ejcts/ezad043. Eur J Cardiothorac Surg. 2023. PMID: 36782361
OBJECTIVES: To elucidate the optimal septal reduction therapy for obstructive hypertrophic cardiomyopathy, we conducted a meta-analysis comparing alcohol septal ablation (ASA) and septal myectomy. METHODS: MEDLINE, EMBASE and Cochr …
OBJECTIVES: To elucidate the optimal septal reduction therapy for obstructive hypertrophic cardiomyopathy, we conducted …
Alcohol Septal Ablation versus Septal Myectomy Treatment of Obstructive Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis.
Bytyçi I, Nistri S, Mörner S, Henein MY. Bytyçi I, et al. J Clin Med. 2020 Sep 23;9(10):3062. doi: 10.3390/jcm9103062. J Clin Med. 2020. PMID: 32977442 Free PMC article. Review.
Surgical myectomy (SM) and alcohol septal ablation (ASA) are two invasive therapies for symptomatic patients with hypertrophic obstructive cardiomyopathy (HOCM), despite medical therapy. ...Thus, ASA and SM treatment of HOCM carry a similar risk …
Surgical myectomy (SM) and alcohol septal ablation (ASA) are two invasive therapies for symptomatic patients with hy …
Alcohol septal ablation vs myectomy for symptomatic hypertrophic obstructive cardiomyopathy: Systematic review and meta-analysis.
Osman M, Kheiri B, Osman K, Barbarawi M, Alhamoud H, Alqahtani F, Alkhouli M. Osman M, et al. Clin Cardiol. 2019 Jan;42(1):190-197. doi: 10.1002/clc.23113. Epub 2018 Nov 29. Clin Cardiol. 2019. PMID: 30421437 Free PMC article.
BACKGROUND: Surgical myectomy (SM) and Alcohol septal ablation (ASA) are effective therapies for patients with hypertrophic cardiomyopathy who remain symptomatic despite medical therapy. ...RESULTS: Twenty-two ASA cohorts (n = 4213; follow-up = …
BACKGROUND: Surgical myectomy (SM) and Alcohol septal ablation (ASA) are effective therapies for patients with hyper …
Gender-Based Outcome Discrepancies in Patients Who Underwent Alcohol Septal Ablation or Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy: A Systematic Review and Meta-Analysis.
Saravanabavanandan R, Jaimalani A, Khan MAN, Riaz S, Mangas GM, Ahsan SM, Posani S, Patel T, Fawad M, Al-Tawil M. Saravanabavanandan R, et al. Am J Cardiol. 2023 Dec 1;208:134-142. doi: 10.1016/j.amjcard.2023.09.033. Epub 2023 Oct 13. Am J Cardiol. 2023. PMID: 37839170 Review.
Clinical evidence and emerging studies suggest that the clinical heterogeneity observed in hypertrophic cardiomyopathy could be because of gender-based differences. ...This strongly emphasizes the need for a gender-specific approach to optimize care and improve trea …
Clinical evidence and emerging studies suggest that the clinical heterogeneity observed in hypertrophic cardiomyopathy could b …
Alcohol Septal Ablation or Septal Myectomy? An Updated Systematic Review and Meta-Analysis of Septal Reduction Therapy for Hypertrophic Obstructive Cardiomyopathy.
Zheng X, Yang B, Hui H, Lu B, Feng Y. Zheng X, et al. Front Cardiovasc Med. 2022 May 25;9:900469. doi: 10.3389/fcvm.2022.900469. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35694661 Free PMC article.
OBJECTIVE: To evaluate the safety and effectiveness of alcohol septal ablation (ASA) and septal myectomy (SM) for the treatment of hypertrophic obstructive cardiomyopathy. ...
OBJECTIVE: To evaluate the safety and effectiveness of alcohol septal ablation (ASA) and septal myectomy (SM) fo …
Radiofrequency ablation in patients with obstructive hypertrophic cardiomyopathy: A systematic review and meta-analysis.
Canzi CC, do Prado Júnior ER, da Silva Menezes Júnior A, Rezende AL, Botelho SM, Santos LDR. Canzi CC, et al. Am Heart J Plus. 2022 Nov 17;24:100229. doi: 10.1016/j.ahjo.2022.100229. eCollection 2022 Dec. Am Heart J Plus. 2022. PMID: 38560638 Free PMC article. Review.
STUDY OBJECTIVE: Hypertrophic cardiomyopathy (HCM) is a genetic disease that can cause left ventricular outflow tract (LVOT) obstruction. ...These results suggest that RA is effective in patients refractory to pharmacological therapy and unsuitable for alcohol …
STUDY OBJECTIVE: Hypertrophic cardiomyopathy (HCM) is a genetic disease that can cause left ventricular outflow tract (LVOT) o …
Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy patients: a systematic review.
Ha HS, Wang N, Wong S, Phan S, Liao J, Kumar N, Qian P, Yan TD, Phan K. Ha HS, et al. J Interv Card Electrophysiol. 2015 Nov;44(2):161-70. doi: 10.1007/s10840-015-0047-8. Epub 2015 Aug 25. J Interv Card Electrophysiol. 2015. PMID: 26302740 Review.
PURPOSE: The primary aim of this systematic review was to assess the efficacy of catheter ablation of atrial fibrillation (AF) in patients with hypertrophic cardiomyopathy (HCM). ...Studies that employed alcohol septal ablation for the tr …
PURPOSE: The primary aim of this systematic review was to assess the efficacy of catheter ablation of atrial fibrillation (AF) in pat …
Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies.
Alam M, Dokainish H, Lakkis N. Alam M, et al. J Interv Cardiol. 2006 Aug;19(4):319-27. doi: 10.1111/j.1540-8183.2006.00153.x. J Interv Cardiol. 2006. PMID: 16881978 Free article. Review.
OBJECTIVE: Alcohol septal ablation (ASA) for hypertrophic obstructive cardiomyopathy (HOCM) has emerged as a lesser invasive alternative to surgical myectomy over the past decade. ...METHODS: MEDLINE and PubMed were searched for all available pu …
OBJECTIVE: Alcohol septal ablation (ASA) for hypertrophic obstructive cardiomyopathy (HOCM) has emerged a …
A systematic review of present and future pharmaco-structural therapies for hypertrophic cardiomyopathy.
Sawan MA, Prabakaran S, D'Souza M, Behbahani-Nejad O, Gold ME, Williams BR, Bilen O. Sawan MA, et al. Clin Cardiol. 2024 Jan;47(1):e24207. doi: 10.1002/clc.24207. Clin Cardiol. 2024. PMID: 38269637 Free PMC article. Review.
Hypertrophic cardiomyopathy (HCM) is a common contemporary, treatable, genetic disorder that can be compatible with normal longevity. ...Conventional pharmacological therapies for symptomatic HCM can help improve symptoms but are often inadequate and poorly tolerate …
Hypertrophic cardiomyopathy (HCM) is a common contemporary, treatable, genetic disorder that can be compatible with normal lon …
15 results